Free Trial

Anpario (LON:ANP) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?

Anpario logo with Consumer Defensive background

Key Points

  • Anpario plc's stock price fell below its two hundred day moving average of GBX 415.98, closing at GBX 415.50 during trading.
  • The company's financial metrics include a debt-to-equity ratio of 0.10 and a market cap of £70.89 million.
  • Anpario specializes in producing natural feed additives for animal health, focusing on gut health and feed quality solutions.
  • Need better tools to track Anpario? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Anpario plc (LON:ANP - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 415.98 ($5.62) and traded as low as GBX 405 ($5.47). Anpario shares last traded at GBX 415.50 ($5.61), with a volume of 16,543 shares traded.

Anpario Trading Down 0.5%

The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. The firm's fifty day simple moving average is GBX 404.14 and its 200-day simple moving average is GBX 415.98. The stock has a market cap of £70.89 million, a P/E ratio of 22.94 and a beta of 0.58.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines